Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
AGU Planungsgesellschaft mbH and TetraScience have announced a new partnership to integrate their flagship products to automatically collect and unify R&D data in life sciences.
read more
Wednesday, January 10, 2018
Aimmune Therapeutics announced an expansion and extension of its exclusive supply agreement with Golden Peanut and Tree Nuts, to support AR101.
read more
Airway Therapeutics and Celonic Group announced a collaboration to produce the novel human recombinant protein AT-100 as a therapeutic candidate against COVID-19.
read more
AIT Laboratories (AIT) has named Kun Ma, MD, Ph.D., MBA to the position of vice president of science and technology. Dr. Ma comes to the company after most recently serving as director of venture analysis at CHV Capital, Inc., and president and CEO ...
read more
Ajinomoto Bio-Pharma Services has entered into a manufacturing services agreement with CytoDyn for the supply of the investigational new drug, leronlimab.
read more
Wednesday, January 27, 2021
Ajinomoto Bio-Pharma Services and Humanigen will be expanding their manufacturing agreement for the fill finish supply of lenzilumab.
read more
Ajinomoto Althea announced that Bert Barbosa and Darwin Richardson, MBA, have joined Althea as Vice President of Drug Product Manufacturing and Vice President of Compliance, respectively.
read more
Tuesday, January 28, 2014
Ajinomoto Althea, Inc., a leading Contract Manufacturing Organization providing development and manufacturing services for biotechnology and pharmaceutical companies, announced today its new product offering, Corynex®, to produce secreted, soluble, ...
read more
Tuesday, September 19, 2017
Ajinomoto Althea will soon open a GMP production suite in its newly constructed HPP commercial manufacturing facility located in San Diego.
read more
Ajinomoto Althea Inc., a leading provider of biotherapeutic contract development and manufacturing services, today announced that the United States Patent and Trademark Office has issued US Patent 9,310,379 covering methods to crystallize monoclonal ...
read more
Wednesday, October 14, 2015
Ajinomoto Althea, Inc. today announced it is expanding its existing biological drug product manufacturing operations to include highly active materials such as Antibody Drug Conjugates (ADCs). The new facility is located in close proximity to ...
read more
Ajinomoto Althea, Inc. announced today it is expanding the capacity of its Fill and Finish operations through the addition of a second manufacturing shift.
read more
Thursday, December 10, 2015
Ajinomoto Althea, Inc. (“Althea”) recently announced it is expanding its existing biological drug product manufacturing operations to include highly active materials such as Antibody Drug Conjugates (ADCs).
read more
Ajinomoto Bio-Pharma Services has completed the acquisition of Granules OmniChem Private, purchasing the remaining 50 percent ownership interest from Granules India.
read more
Ajinomoto Bio-Pharma Services has announced the launch of AJILITY™, a flexible and agile drug product manufacturing platform.
read more